Sanyuan Biotechnology
30120623.530.34% ( +0.08 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Sanyuan Biotechnology(301206) the Revenue is 224.78 M (+49.65%);the EBIT is 18.86 M (+185.3%);the EPS is 0.13 (+8.33%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.22B49.65%
----
----
EBIT
0.02B185.31%
----
----
EPS
0.138.33%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf